Physician profile
Ryan Floyd
NPI 1437584851
$11,102.15
in general payments reported to CMS, 2019-2025
18 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $30.38 · 2022: $271 · 2023: $4,132 · 2024: $6,276 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,000 · Travel and Lodging: $1,065 · Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,000.00 |
| Travel and Lodging | $1,064.59 |
| Food and Beverage | $606.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,403.67 | 2019-2025 | Ion, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $168.09 | 2022-2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $98.58 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $95.24 | 2024 | Fujifilm |
| Harmony Biosciences LLC | $52.77 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $52.25 | 2022-2025 | Airsupra |
| Regeneron Healthcare Solutions, INC. | $32.53 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.54 | 2022 | |
| Verona Pharma, INC. | $23.11 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $20.33 | 2020 | |
| Olympus America INC. | $20.00 | 2025 | |
| Electromed, INC. | $19.84 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $19.52 | 2022 | |
| Amgen INC. | $16.96 | 2022 | |
| Inari Medical, INC. | $16.21 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $11.65 | 2022 | |
| Inogen, INC. | $10.81 | 2022 | |
| Ambu INC. | $10.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.